SpiderRock Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Hold
0
-$380 743
2023
Q4
Hold
0
139
2023
Q3
Hold
0
125
2022
Q1
Hold
0
-$338K 163
2021
Q4
Hold
0
97
2021
Q3
Hold
0
73
2021
Q2
Hold
0
71
2021
Q1
Hold
0
68
2020
Q4
Hold
0
141
2020
Q3
Hold
0
-$54K 182
2020
Q2
Hold
0
140
2017
Q4
Hold
0
-$48K 297
2017
Q3
Hold
0
218
2017
Q2
Hold
0
212
2017
Q1
Hold
0
54

Other funds holding PFE

SpiderRock Advisors's PFE Position: Q3 2024 in Review

SpiderRock Advisors reduced its Pfizer (PFE) stake by 2.6% in Q3 2024, selling an estimated $156K and leaving 198,616 shares worth $5.75M. The position accounts for 0.09% of the portfolio, ranked #160.

SpiderRock Advisors first reported a position in PFE in Q1 2024 and has held it in 3 quarters since. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • SpiderRock Advisors held 198,616 shares of Pfizer worth $5.75M as of Q3 2024.
  • SpiderRock Advisors sold 5,353 Pfizer shares in Q3 2024, an estimated $156K.
  • Pfizer made up 0.09% of SpiderRock Advisors's portfolio in Q3 2024, its #160 holding.
  • SpiderRock Advisors first reported a position in Pfizer in Q1 2024 and has held it in 3 quarters since.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.